Type
. Comparative proteomics of the Mycobacterium leprae binding protein myelin P0: its implication in leprosy and other neurodegenerative diseases. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2004;4(1):21-8.
Type
. Leprosy in Nkhotakota District Hospital. East African medical journal [Internet]. 2003;80(12):635-9. Available from: http://www.ajol.info/index.php/eamj/article/view/8780
Type
. [Current guidelines for leprosy treatment]. Bulletin de la Societe de pathologie exotique (1990). 2003;96(5):357-61.
Type
. Linkage analysis of susceptibility to leprosy type using an IBD regression method. Genes and immunity [Internet]. 2004;5(3):221-5. Available from: http://www.nature.com/gene/journal/v5/n3/pdf/6364062a.pdf
Type
. Leprosy control strategies and the integration of health services: an international perspective. Cadernos de saude publica [Internet]. 2003;19(6):1567-81. Available from: http://www.scielosp.org/pdf/csp/v19n6/a02v19n6.pdf
Type
. Leprosy: dental and periodontal status of the anterior maxilla in 76 patients. Oral diseases. 2004;10(1):19-21.
Type
. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy. The American journal of tropical medicine and hygiene. 2004;70(2):197-200.
Type
. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. The Journal of clinical investigation. 2004;113(5):701-8.
Type
. [Health service organization during the age of pestilence. 2]. Le infezioni in medicina. 2003;11(4):216-21.
Type
. Leprosy in children: association between clinical and pathological aspects. Journal of tropical pediatrics. 2004;50(1):12-5.